1、 ZHOU JJ, CHEN RF, DENG XG, et al. Hepatitis C virus core protein regulates NANOG expression via the stat3 pathway[J]. FEBS Lett, 2014, 588(4):566-573. ZHOU JJ, CHEN RF, DENG XG, et al. Hepatitis C virus core protein regulates NANOG expression via the stat3 pathway[J]. FEBS Lett, 2014, 588(4):566-573.
2、 LEE CH, CHANG CJ, LIN YJ, et al. Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma[J]. Br J Cancer, 2009, 100(11):1765-1770. LEE CH, CHANG CJ, LIN YJ, et al. Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma[J]. Br J Cancer, 2009, 100(11):1765-1770.
3、 El-SERAG HB, ENGELS EA, LANDGREN O, et al. Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans[J]. Hepatology, 2009, 49(1):116-123. El-SERAG HB, ENGELS EA, LANDGREN O, et al. Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans[J]. Hepatology, 2009, 49(1):116-123.
4、 NAKAMURA H, AOKI H, HINO O, et al. HCV core protein promotes heparin binding EGF-like growth factor expression and activates Akt[J]. Hepatol Res, 2011, 41(5):455-462. NAKAMURA H, AOKI H, HINO O, et al. HCV core protein promotes heparin binding EGF-like growth factor expression and activates Akt[J]. Hepatol Res, 2011, 41(5):455-462.
5、 MACHIDA K, TSUKAMOTO H, LIU JC, et al. c-Jun mediates hepatitis C virus hepatocarcinogenesis through signal transducer and activator of transcription 3 and nitric oxide-dependent impairment of oxidative DNA repair[J]. Hepatology, 2010, 52(2):480-492. MACHIDA K, TSUKAMOTO H, LIU JC, et al. c-Jun mediates hepatitis C virus hepatocarcinogenesis through signal transducer and activator of transcription 3 and nitric oxide-dependent impairment of oxidative DNA repair[J]. Hepatology, 2010, 52(2):480-492.
6、 LIU C, QU A, HAN X, et al. HCV core protein represses the apoptosis and improves the autophagy of human hepatocytes[J]. Int J Clin Exp Med, 2015, 8(9):15787-15793. LIU C, QU A, HAN X, et al. HCV core protein represses the apoptosis and improves the autophagy of human hepatocytes[J]. Int J Clin Exp Med, 2015, 8(9):15787-15793.
7、 MOON J, KAOWINN S, CHO IR, et al. Hepatitis C virus core protein enhances hepatocellular carcinoma cells to be susceptible to oncolytic vesicular stomatitis virus through down-regulation of HDAC4[J]. Biochem Biophys Res Commun, 2016, 474(3):428-434. MOON J, KAOWINN S, CHO IR, et al. Hepatitis C virus core protein enhances hepatocellular carcinoma cells to be susceptible to oncolytic vesicular stomatitis virus through down-regulation of HDAC4[J]. Biochem Biophys Res Commun, 2016, 474(3):428-434.
8、 KOZIEL MJ, PETERS MG. Viral hepatitis in HIV infection[J]. N Engl J Med, 2007, 356(14):1445-1454. KOZIEL MJ, PETERS MG. Viral hepatitis in HIV infection[J]. N Engl J Med, 2007, 356(14):1445-1454.
9、 TAN Y, LI Y. HCV core protein promotes hepatocyte proliferation and chemoresistance by inhibitingNR4A1[J]. Biochem Biophys Res Commun, 2015, 466(3):592-598. TAN Y, LI Y. HCV core protein promotes hepatocyte proliferation and chemoresistance by inhibitingNR4A1[J]. Biochem Biophys Res Commun, 2015, 466(3):592-598.
10、 KWAK J, SHIM JH, TIWARI I, et al. Hepatitis C virus core protein inhibits E6AP expression via DNA methylation to escape from ubiquitin-dependent proteasomal degradation[J]. Cancer Lett, 2016, 380(1):59-68. KWAK J, SHIM JH, TIWARI I, et al. Hepatitis C virus core protein inhibits E6AP expression via DNA methylation to escape from ubiquitin-dependent proteasomal degradation[J]. Cancer Lett, 2016, 380(1):59-68.
11、 ZENG B, LI Z, CHEN R, et al. Epigenetic regulation of miR-124 by hepatitis C virus core protein promotes migration and invasion of intrahepatic cholangiocarcinoma cells by targeting SMYD3[J]. FEBS Lett, 2012, 586(19):3271-3278. ZENG B, LI Z, CHEN R, et al. Epigenetic regulation of miR-124 by hepatitis C virus core protein promotes migration and invasion of intrahepatic cholangiocarcinoma cells by targeting SMYD3[J]. FEBS Lett, 2012, 586(19):3271-3278.
12、 SEMPOUX C, JIBARA G, WARD SC, et al. Intrahepatic cholangiocarcinoma: new insights in pathology[J]. Semin Liver Dis, 2011, 31(1):49-60. SEMPOUX C, JIBARA G, WARD SC, et al. Intrahepatic cholangiocarcinoma: new insights in pathology[J]. Semin Liver Dis, 2011, 31(1):49-60.
13、 BARTOSCH B TR, BLUM HE, et al. Hepatitis C virus-induced hepatocarcinogenesis[J]. J Hepatol, 2009, 51(4):810-820. BARTOSCH B TR, BLUM HE, et al. Hepatitis C virus-induced hepatocarcinogenesis[J]. J Hepatol, 2009, 51(4):810-820.
